Braidwell LP Harrow Health, Inc. Put Options Transaction History
Braidwell LP
- $1.79 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HROW
# of Institutions
183Shares Held
21.1MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$122 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$65.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$57.1 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$51.7 Million6.85% of portfolio
-
State Street Corp Boston, MA828KShares$25.2 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $825M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...